Oxford Molecular

Oxford Molecular Group was a pioneering bioinformatics and drug discovery software company founded in 1989 as a spin-out from the University of Oxford. The company specialized in developing molecular modeling, chemical information systems, and genomic analysis tools to accelerate the drug design process. At its peak, it was a leading provider of computer-aided molecular design (CAMD) software to the pharmaceutical and biotechnology industries. The company was listed on the London Stock Exchange before its software division was acquired by Pharmacopeia in 2000. Its legacy continues through the integration of its technologies into modern life science software platforms like BIOVIA.